Semax & Selank

A synergistic research bundle designed for cognitive enhancement and stress modulation.

Price range: $260.00 through $620.00

SELECT PROTOCOL DURATION
All products sold on this website are intended for research and identification purposes. These products are not intended for human dosing, injection, or ingestion.

Description Semax & Selank

Exciting Research Findings:

Reduced Anxiousness Published in 2020, this human resting-state fMRI study in 52 healthy participants showed that Selank injection rapidly altered functional connectivity in anxiety-related brain regions (amygdala) and executive function areas (dorsolateral prefrontal cortex), with effects observed 5-20 minutes post-injection, supporting its quick-onset anxiolytic mechanism. Improved Stress Response Published in 2020, this preclinical study in rats demonstrated that daily intraperitoneal Selank (100 mcg/kg) over 20 days under social stress significantly reduced pro-inflammatory cytokines (IL-1B, IL-6, TNF-α, TGF-β1) to near-control levels, indicating strong anti-inflammatory and stress-protective effects. Reduced Withdrawal-Related Anxiety Published in 2022, this rat study found that a single intraperitoneal injection of Selank (0.3 mg/kg) reduced morphine withdrawal symptoms by ~40% (e.g., convulsions, ptosis, allodynia), comparable to diazepam but with a distinct profile, highlighting its potential in managing withdrawal-related anxiety.

About Semax & Selank

When the peptide Selank is injected, the GABA receptors are stimulated, promoting relaxation and calmness while reducing tension and restlessness. Selank has been shown to enhance cognitive function, reduce anxiety and stress, improve mood and sleep, and boost the immune response.

📖 Clinical Research Findings

Peer-Reviewed Literature
2020

Reduced Anxiousness

Published in 2020, this human resting-state fMRI study in 52 healthy participants showed that Selank injection rapidly altered functional connectivity in anxiety-related brain regions (amygdala) and executive function areas (dorsolateral…

Read Paper →
2020

Improved Stress Response

Published in 2020, this preclinical study in rats demonstrated that daily intraperitoneal Selank (100 mcg/kg) over 20 days under social stress significantly reduced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, TGF-β1) to…

Read Paper →
2022

Reduced Withdrawal-Related Anxiety

Published in 2022, this rat study found that a single intraperitoneal injection of Selank (0.3 mg/kg) reduced morphine withdrawal symptoms by ~40% (e.g., convulsions, ptosis, allodynia), comparable to diazepam but…

Read Paper →

Protocol Components

Dual Molecular Synergy
Semax

COGNITION

Semax is a synthetic peptide known for its neuroprotective and cognitive-enhancing properties. Originally developed for treating stroke and cognitive disorders, research indicates its potential in modulating brain-derived neurotrophic factor (BDNF).

Primary Physiological Targets
  • Enhances cognitive function and memory consolidation.
  • Promotes neurogenesis and protects neurons.
  • Improves attention and focus in research models.

Semax Heptapeptide (ACTH 4-10 Analog) >99% HPLC

Selank

RELAXATION

Selank is a synthetic analog of the naturally occurring peptide tuftsin. It is extensively researched for its anxiolytic (anti-anxiety) effects and its ability to modulate the expression of Interleukin-6 and GABA receptors, promoting a state of calm focus.

Primary Physiological Targets
  • Modulates anxiety and stress responses.
  • Influences GABAergic neurotransmission.
  • Stabilizes mood without sedative side effects.

Selank Synthetic Heptapeptide (Tuftsin Analog) >99% HPLC